J.D., The George Washington University with high honors
Ph.D., Chemistry, Harvard University
B.S., Chemistry, Rensselaer Polytechnic Institute
IAM Patent 1000 2013 Recommended Lawyer
Best Lawyers' 2013 Washington DC Biotechnology Law 'Lawyer of the Year'
2012 LMG Life Sciences ‘Star’
Washington DC Super Lawyers 2008-2013
Leading Lawyer in IP, Chambers USA, 2006-2012
International Who's Who of Patent Lawyers 2011
IAM 250 - Leading Life Science Lawyer, 2010
Best Lawyers in America 2008-2014
Leading Lawyer in the Life Sciences, Chambers USA, 2007-2012
Key Figure in Interferences, The Legal 500 U.S., 2007-2008
Certified Licensing Professional 2008
Martindale AV Preeminent Peer Rating 5.0/5.0
District of Columbia
United States Patent and Trademark Office
Court of Appeals for the Federal Circuit
American Association for the Advancement of Science
American Chemical Society
American Intellectual Property Law Association Biotechnology Committee
Biotechnology Industry Association
"The IAM Strategy 250 identifies individuals who offer world-class services related to the development and implementation of strategies which enable IP owners to maximise the value of their rights portfolios"
-Joff Wild, Editor, IAM Magazine
"One of the best biotechnology lawyers in the country"
- IAM Patent 1000 2013
Jorge A. Goldstein, Ph.D.
He is considered by his peers and clients to be one of the country’s pioneers in biotechnology patent law. He has more than thirty years’ experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, organic synthesis, pharmaceuticals and polymers.
Jorge heads both the firm’s Biotechnology Practice Group and the Intellectual Property and Human Rights Pro Bono Practice. He has handled multiple and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He chairs the firm’s Inventorship Dispute Resolution Service and serves as a Neutral Mediator/Arbitrator as part of Ocean Tomo’s ADR Service. He has also been involved in oppositions, and arbitrations in District Court and in Appellate litigation both as counsel and expert witness, and in counseling clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements.
He has also been named Extraordinary Professor of Law by the Universidad Austral in Buenos Aires, Argentina, where he teaches biotech patent law in the only WIPO-certified regional master's IP program in Latin America.
"Biotechnology Patent Pools and Standard Setting," Chapter in Patent Law: A Handbook of Contemporary Research, Edward Elgar Publishing.
“In re Wands Turns 20 This Year and is Increasingly Influencing the Written Description Requirement in Biotechnology,” IP Today, August 2008, pages 1-3.
"Patentes Respecto de Genes Humanos," 4 Anuario Andino de Derechos Intelectuales 173 (Lima, Peru 2008.)
"Scientific Collaborations and Inventorship Disputes," 12 IP Litigator 18, November/December 2006.